Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)

Volume 29, Issue 6, June 2019, Page 407-427 .

Source: Expert Opinion on Therapeutic Patents - May 27, 2019 Category: Drugs & Pharmacology Authors: Sayyed Mohammad Ismail Mahboubi Rabbani Afshin Zarghi Source Type: research